Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

1.

A QM-MD simulation approach to the analysis of FRET processes in (bio)molecular systems. A case study: complexes of E. coli purine nucleoside phosphorylase and its mutants with formycin A.

Sobieraj M, Krzyśko KA, Jarmuła A, Kalinowski MW, Lesyng B, Prokopowicz M, Cieśla J, Gojdź A, Kierdaszuk B.

J Mol Model. 2015 Apr;21(4):75. doi: 10.1007/s00894-015-2602-8. Epub 2015 Mar 10.

2.

Analogs of cinnamic acid benzyl amide as nonclassical inhibitors of activated JAK2 kinase.

Mielecki M, Milner-Krawczyk M, Grzelak K, Mielecki D, Krzysko KA, Lesyng B, Priebe W.

Curr Cancer Drug Targets. 2014;14(7):638-51.

PMID:
25146330
3.

Development of novel molecular probes of the Rio1 atypical protein kinase.

Mielecki M, Krawiec K, Kiburu I, Grzelak K, Zagórski W, Kierdaszuk B, Kowa K, Fokt I, Szymanski S, Swierk P, Szeja W, Priebe W, Lesyng B, LaRonde-LeBlanc N.

Biochim Biophys Acta. 2013 Jul;1834(7):1292-301. doi: 10.1016/j.bbapap.2013.03.012. Epub 2013 Mar 20.

PMID:
23523885
4.

Thermal fluctuations and infrared spectra of the formamide-formamidine complex.

Walewski L, Smaga A, Lesyng B, Sadlej J.

J Phys Chem A. 2012 Oct 25;116(42):10412-9. doi: 10.1021/jp3054636. Epub 2012 Oct 15.

PMID:
23030245
5.

Novel small molecular inhibitors disrupt the JAK/STAT3 and FAK signaling pathways and exhibit a potent antitumor activity in glioma cells.

Swiatek-Machado K, Mieczkowski J, Ellert-Miklaszewska A, Swierk P, Fokt I, Szymanski S, Skora S, Szeja W, Grynkiewicz G, Lesyng B, Priebe W, Kaminska B.

Cancer Biol Ther. 2012 Jun;13(8):657-70. doi: 10.4161/cbt.20083. Epub 2012 Jun 1.

PMID:
22555804
6.

Vibrations and hydrogen bonding in porphycene.

Gawinkowski S, Walewski Ł, Vdovin A, Slenczka A, Rols S, Johnson MR, Lesyng B, Waluk J.

Phys Chem Chem Phys. 2012 Apr 28;14(16):5489-503. doi: 10.1039/c2cp24098j. Epub 2012 Mar 13.

PMID:
22415158
7.

Activities of topoisomerase I in its complex with SRSF1.

Ishikawa T, Krzysko KA, Kowalska-Loth B, Skrajna AM, Czubaty A, Girstun A, Cieplak MK, Lesyng B, Staron K.

Biochemistry. 2012 Feb 28;51(8):1803-16. doi: 10.1021/bi300043t. Epub 2012 Feb 15.

PMID:
22320324
8.

A novel method to compare protein structures using local descriptors.

Daniluk P, Lesyng B.

BMC Bioinformatics. 2011 Aug 17;12:344. doi: 10.1186/1471-2105-12-344.

9.

A genistein derivative, ITB-301, induces microtubule depolymerization and mitotic arrest in multidrug-resistant ovarian cancer.

Ahmed AA, Goldsmith J, Fokt I, Le XF, Krzysko KA, Lesyng B, Bast RC Jr, Priebe W.

Cancer Chemother Pharmacol. 2011 Oct;68(4):1033-44. doi: 10.1007/s00280-011-1575-2. Epub 2011 Feb 22.

10.

Car-Parrinello molecular dynamics study of the intramolecular vibrational mode-sensitive double proton-transfer mechanisms in porphycene.

Walewski Ł, Waluk J, Lesyng B.

J Phys Chem A. 2010 Feb 18;114(6):2313-8. doi: 10.1021/jp907754r.

PMID:
20099852
11.
12.

RRM proteins interacting with the cap region of topoisomerase I.

Trzcińska-Daneluti AM, Górecki A, Czubaty A, Kowalska-Loth B, Girstun A, Murawska M, Lesyng B, Staroń K.

J Mol Biol. 2007 Jun 15;369(4):1098-112. Epub 2007 Apr 12.

PMID:
17481653
13.

Implementation of a symplectic multiple-time-step molecular dynamics algorithm, based on the united-residue mesoscopic potential energy function.

Rakowski F, Grochowski P, Lesyng B, Liwo A, Scheraga HA.

J Chem Phys. 2006 Nov 28;125(20):204107.

PMID:
17144690
14.

Efficacy of 2-halogen substituted D-glucose analogs in blocking glycolysis and killing "hypoxic tumor cells".

Lampidis TJ, Kurtoglu M, Maher JC, Liu H, Krishan A, Sheft V, Szymanski S, Fokt I, Rudnicki WR, Ginalski K, Lesyng B, Priebe W.

Cancer Chemother Pharmacol. 2006 Dec;58(6):725-34. Epub 2006 Mar 23.

PMID:
16555088
15.

Prediction of secondary ionization of the phosphate group in phosphotyrosine peptides.

Wojciechowski M, Grycuk T, Antosiewicz JM, Lesyng B.

Biophys J. 2003 Feb;84(2 Pt 1):750-6.

16.

Structural basis of oncogenic activation caused by point mutations in the kinase domain of the MET proto-oncogene: modeling studies.

Miller M, Ginalski K, Lesyng B, Nakaigawa N, Schmidt L, Zbar B.

Proteins. 2001 Jul 1;44(1):32-43.

PMID:
11354004
18.

Quantum-dynamical picture of a multistep enzymatic process: reaction catalyzed by phospholipase A(2).

Bała P, Grochowski P, Nowiński K, Lesyng B, McCammon JA.

Biophys J. 2000 Sep;79(3):1253-62.

19.

A simple model for predicting the free energy of binding between anthracycline antibiotics and DNA.

Rudnicki WR, Kurzepa M, Szczepanik T, Priebe W, Lesyng B.

Acta Biochim Pol. 2000;47(1):1-9.

20.

A mezoscopic model of nucleic acids. Part 2. An effective potential energy function for DNA.

Maciejczyk M, Rudnicki WR, Lesyng B.

J Biomol Struct Dyn. 2000 Jun;17(6):1109-15.

PMID:
10949176
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk